Rosa’s Derek Bartlett to Present Work on Mechanistic Modeling in Diabetes Drug Design at the AAPS Conference

Dr. Bartlett will discuss the use of modeling to evaluate combination therapies for diabetes, November 13th, 2013 in San Antonio, Texas. - November 13, 2013

Rosa & Co CEO, Dr. Ron Beaver Presents "Systems Pharmacology: First Principles to Effective Practice" in the Plenary Session of the Integrating Pharmacometrics Summit

Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, announced that Dr. Ron Beaver, CEO, presented a plenary session talk at the Hanson Wade Integrating Pharmacometrics Summit (October 21st -23rd 2013), Munich, Germany, entitled... - November 13, 2013

Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference

Rosa’s Toufigh Gordi to Present Models and Their Utility in Drug Development at Target Meeting’s 3rd World Drug Discovery Online Conference

Dr. Toufigh Gordi will discuss the application of modeling at different stages in the drug development process, October 16th, 2013. - October 08, 2013

Dr. Dean Bottino, Roche, to Discuss Multi-Scale Modeling in Development of Cancer Drugs in Rosa’s Impact Webinar Series

Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013. - May 28, 2013

Dr. Toufigh Gordi to Discuss the Selection of Appropriate Mathematical Modeling Techniques in Drug Development at 4th World PK/PD Summit

Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process on November 28, 2012 in Frankfort, Germany. - November 08, 2012

Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa’s Impact Webinar Series

Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012. - October 10, 2012

Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa’s Impact Webinar Series

Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012. - September 08, 2012

GlaxoSmithKline and Rosa Present Psoriasis Collaboration Results at 17th International IRA Conference

PhysioPD™ modeling collaboration in psoriasis to be presented September 9-13, 2012. - August 14, 2012

Rosa to Present Mechanistic Systems Pharmacology Workshop at 2012 ICSB Conference

Workshop focused on Rosa’s Model Qualification Method to be held August 19th, Toronto, Canada. - August 02, 2012

Dr. Scott Siler to Discuss DILIsym Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012. - June 12, 2012

Rosa to Present Beta Cell Mass Research at 2012 ADA Annual Meeting

Modeling analysis enables development of clinical markers for beta cell mass. - June 02, 2012

Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012. - May 18, 2012

Dr. Birgit Schoeberl to Discuss Using Mathematical Models to Set Design Criteria for Antibody-Based Therapies in Rosa’s "Impact" World-Wide Webinar Series

Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. - April 04, 2012

Rosa to Present Two Lectures at the European Foundation of Medicinal Chemists Conference

Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling - April 01, 2012

Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit

Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012

Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology

Modeling analysis enables development of biomarkers for beta cell mass. - March 24, 2012

Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012

Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012

PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012

Rosa Announces Publication of Its PhysioPD™ Model Qualification Method and Series of Educational Events

Series of Seminars and Workshops to be held in 2012 across the US and in Europe. - March 01, 2012

Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development

Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity. - February 07, 2012

Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Derendorf, will present “PK/PD-based Development of Anti-infective Agents” February 13, 2012. - February 06, 2012

Rosa to Present at 2012 Keystone Symposia: Cancer and Metabolism

Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. - February 03, 2012

Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics

Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012

Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes

Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012

Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012

Integration of PK/PD and mechanistic physiological models improves drug development in infants. - January 24, 2012

Rosa to Provide Noncompartmental Pharmacokinetic Analyses NCAs for Advanced Research Institute

Integration Creates Seamless Data Management and Analysis Capability for ARA Customers - November 14, 2011

Dr. Mike Reed Joins Rosa & Co. Executive Management Team

Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Mike Reed as Vice President. - November 01, 2011

Dr. Rebecca Baillie to Present in Rosa’s World-Wide Webinar Series, "Impact of Modeling & Simulation in Drug Development"

Dr. Rebecca Baillie, will present a webinar in Rosa’s monthly public webinar series “How to build a PhysioPD model” on June 20, 2011 at 1:00 pm EDT (GMT -5:00). - June 09, 2011

Rosa Announces Qualification of a Novel Methodology for Prediction of Pediatric Clinical Pharmacology Data in Bile Acid Metabolism

A PhysioPD™ model of bile acid metabolism has incorporated ‘omics data to predict ursodiol clinical data and explain inter-individual variability. - April 28, 2011

Rosa Diabetes PhysioPD™ Collaboration with Pfizer to be Presented at World PK/PD Summit

Diabetes PhysioPD model used to predict long-term clinical outcomes and select doses using only summary pharmacokinetic data from a competitor’s short-term Phase I clinical trial - April 23, 2011

Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

You are invited to attend Dr. Goburru’s webinar The “Learn & Apply” Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00) (www.rosaandco.com/webinar). This talk will summarize the state of the art in applying drug-disease-trial modeling to decision-making processes in drug development. - April 08, 2011

Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011

In collaboration with its clients, Lithera, MediciNova, Pfizer, Vitalea, Rosa & Co will present six posters at the 2011 American College on Pharmacometrics in San Diego, CA on April 4, 2011. The posters describe the use of drug-disease modeling in pharmaceutical development. - March 22, 2011

Rosa & Co. Announces the Appointment of Sharan A. Pagano as Vice President, Scientific Alliances, and the Opening of Rosa’s Boston-Area Office

Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Sharan A. Pagano, Vice President, Scientific Alliances, responsible for worldwide sales and account development, and the opening of Rosa’s new Boston, MA-area office. - March 09, 2011

Rosa & Co and Vitalea Science to Present at ASPCT 2011 Meeting

In collaboration with Vitalea Science, Inc., Rosa & Co will present a poster at the 2011 American Society for Clinical Pharmacology and Therapeutics in Dallas, TX entitled "Compartmental Analysis of Urosodiol PK in Neonates using AMS " at 8:00 am on March 4, 2011. - February 16, 2011

Press Releases 1 - 34 of 34